Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus and Chronic Obstructive Pulmonary Disease

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40656

Related search